Literature DB >> 12939597

Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver.

Jong Eun Yeon1, Sophia Califano, Julia Xu, Jack R Wands, Suzanne M De La Monte.   

Abstract

Chronic ethanol consumption can cause sustained hepatocellular injury and inhibit the subsequent regenerative response. These effects of ethanol may be mediated by impaired hepatocyte survival mechanisms. The present study examines the effects of ethanol on survival signaling in the intact liver. Adult Long Evans rats were maintained on ethanol-containing or isocaloric control liquid diets for 8 weeks, after which the livers were harvested to measure mRNA levels, protein expression, and kinase or phosphatase activity related to survival or proapoptosis mechanisms. Chronic ethanol exposure resulted in increased hepatocellular labeling for activated caspase 3 and nuclear DNA damage as demonstrated using the TUNEL assay. These effects of ethanol were associated with reduced levels of tyrosyl phosphorylated (PY) IRS-1 and PI3 kinase, Akt kinase, and Erk MAPK activities and increased levels of phosphatase tensin homologue deleted on chromosome 10 (PTEN) mRNA, protein, and phosphatase activity in liver tissue. In vitro experiments demonstrated that ethanol increases PTEN expression and function in hepatocytes. However, analysis of signaling cascade pertinent to PTEN function revealed increased levels of nuclear p53 and Fas receptor mRNA but without corresponding increases in GSK-3 activity or activated BAD. Although fork-head transcription factor levels were increased in ethanol-exposed livers, virtually all of the fork-head protein detected by Western blot analysis was localized within the cytosolic fraction. In conclusion, chronic ethanol exposure impairs survival mechanisms in the liver because of inhibition of signaling through PI3 kinase and Akt and increased levels of PTEN. However, uncoupling of the signaling cascade downstream of PTEN that mediates apoptosis may account for the relatively modest degrees of ongoing cell loss observed in livers of chronic ethanol-fed rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939597     DOI: 10.1053/jhep.2003.50368

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

1.  The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver.

Authors:  Julia I-Ju Leu; Maureen E Murphy; Donna L George
Journal:  J Liver       Date:  2013

2.  Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance.

Authors:  Suzanne M de la Monte; Maoyin Pang; Rajeev Chaudhry; Kevin Duan; Lisa Longato; Jade Carter; Jiyun Ouh; Jack R Wands
Journal:  Hepatol Res       Date:  2011-02-24       Impact factor: 4.288

3.  PTEN in liver diseases and cancer.

Authors:  Marion Peyrou; Lucie Bourgoin; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

4.  Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.

Authors:  Ming Tong; Lisa Longato; Teresa Ramirez; Valerie Zabala; Jack R Wands; Suzanne M de la Monte
Journal:  Int J Exp Pathol       Date:  2013-10-29       Impact factor: 1.925

5.  Chronic alcohol-induced liver disease inhibits dendritic cell function.

Authors:  Dechun Feng; Ahmet Eken; Vivian Ortiz; Jack R Wands
Journal:  Liver Int       Date:  2011-03-21       Impact factor: 5.828

6.  Adenylyl cyclases types 1 and 8 promote pro-survival pathways after ethanol exposure in the neonatal brain.

Authors:  Alana C Conti; Chainllie Young; John W Olney; Louis J Muglia
Journal:  Neurobiol Dis       Date:  2008-10-17       Impact factor: 5.996

7.  Rat strain differences in susceptibility to alcohol-induced chronic liver injury and hepatic insulin resistance.

Authors:  Sarah M Denucci; Ming Tong; Lisa Longato; Margot Lawton; Mashiko Setshedi; Rolf I Carlson; Jack R Wands; Suzanne M de la Monte
Journal:  Gastroenterol Res Pract       Date:  2010-08-16       Impact factor: 2.260

8.  Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.

Authors:  Lascelles E Lyn-Cook; Margot Lawton; Ming Tong; Elizabeth Silbermann; Lisa Longato; Ping Jiao; Princess Mark; Jack R Wands; Haiyan Xu; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  Mechanisms of ceramide-mediated neurodegeneration.

Authors:  Ming Tong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 10.  The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Sarah DeNucci; Jack R Wands
Journal:  Int J Environ Res Public Health       Date:  2009-07-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.